NEW YORK -- A U.S. appeals court vacated an injunction Tuesday that limited the evidence former fen-phen users could present in state court litigation against Madison, N.J.-based Wyeth. The ruling is a boost for the plaintiffs, who had opted out of a pending class-action settlement of $3.75 billion and are pursuing their own claims. Wyeth has paid out about $1 billion from the AHP Settlement Trust set up in 1999 to compensate people who took Pondimin or Redux and to settle class-action lawsuits.
Posted by Editor at June 8, 2004 03:06 PM